PLYMOUTH MEETING, Pa., Jan. 5, 2011 /PRNewswire/ -- BioBehavioral Diagnostics Company (BioBDx), a privately held diagnostics company which manufactures and markets the Quotient® ADHD System, a tool that aids in the objective and accurate assessment of attention-deficit hyperactivity disorder (ADHD), announced today that Byron Hewett, executive chairman, has been selected to present at Biotech Showcase 2011 in San Francisco, CA.
Mr. Hewett's presentation will be given at the Parc 55 Wyndham Hotel on Tuesday, January 11, 2011 at 1:45 p.m. PST. The presentation will also be available via web cast at: http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=W242090&item_id=3599550.
About the Quotient® ADHD SystemThe Quotient® ADHD System measures motion and analyzes shifts in attention state to give an objective picture of the core symptom areas of ADHD. Clinicians use the Quotient® ADHD Test at the initial visit to assess severity of the three core symptoms of ADHD; hyperactivity, inattention and impulsivity. Patients may be re-assessed periodically at follow-up visits to guide treatment plans. The clinician integrates the Quotient® ADHD Test report with information from other assessment tools and the clinical evaluation to help guide the discussion on the treatment plan. For more information about the Quotient® ADHD System, please visit http://www.biobdx.com/Products/QuotientADHDSystem.aspx.
About BioBehavioral Diagnostics CompanyBioBDx manufactures and markets the Quotient® ADHD System, a tool that aids in the objective and accurate assessment of ADHD symptom areas. We are dedicated to providing physicians, parents and patients with high-value information to guide personalized strategies and to enhan
|SOURCE BioBehavioral Diagnostics Company|
Copyright©2010 PR Newswire.
All rights reserved